The SPDR S&P Biotech ETF is already up 5.9 percent this year, and during the JPMorgan Healthcare Conference Jan. 9-12, AstraZeneca, Ipsen and Chiesi announced separate deals in the $1 billion range.
The HHS timeline for Medicare drug-price negotiations has eased investors’ fears, the Journal reported.
Merck CEO Robert Davis used the word “confident” more than 20 times in his presentation at the JPMorgan healthcare conference, setting the tone for how the biotech industry feels in 2023.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
